BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 26968993)

  • 1. Insight into specific pro-arrhythmic triggers in Brugada and early repolarization syndromes: results of long-term follow-up.
    Talib AK; Sato N; Myojo T; Sugiyama E; Nakagawa N; Sakamoto N; Tanabe Y; Fujino T; Takeuchi T; Akasaka K; Matsuhashi H; Saijo Y; Kawamura Y; Doi A; Hasebe N
    Heart Vessels; 2016 Dec; 31(12):2035-2044. PubMed ID: 26968993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrical storm in patients with brugada syndrome is associated with early repolarization.
    Kaneko Y; Horie M; Niwano S; Kusano KF; Takatsuki S; Kurita T; Mitsuhashi T; Nakajima T; Irie T; Hasegawa K; Noda T; Kamakura S; Aizawa Y; Yasuoka R; Torigoe K; Suzuki H; Ohe T; Shimizu A; Fukuda K; Kurabayashi M; Aizawa Y
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1122-8. PubMed ID: 25221333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of early repolarization in inferolateral leads in Brugada patients with documented ventricular fibrillation: a novel risk factor for Brugada syndrome with ventricular fibrillation.
    Kawata H; Morita H; Yamada Y; Noda T; Satomi K; Aiba T; Isobe M; Nagase S; Nakamura K; Fukushima Kusano K; Ito H; Kamakura S; Shimizu W
    Heart Rhythm; 2013 Aug; 10(8):1161-8. PubMed ID: 23587501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrocardiographic parameters and fatal arrhythmic events in patients with Brugada syndrome: combination of depolarization and repolarization abnormalities.
    Tokioka K; Kusano KF; Morita H; Miura D; Nishii N; Nagase S; Nakamura K; Kohno K; Ito H; Ohe T
    J Am Coll Cardiol; 2014 May; 63(20):2131-2138. PubMed ID: 24703917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of electrocardiographic risk markers for the initial and recurrent episodes of ventricular fibrillation in patients with Brugada syndrome.
    Morita H; Watanabe A; Kawada S; Miyamoto M; Morimoto Y; Nakagawa K; Nishii N; Nakamura K; Ito H
    J Cardiovasc Electrophysiol; 2018 Jan; 29(1):107-114. PubMed ID: 28940628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exaggerated Reactivity of Parasympathetic Nerves Is Involved in Ventricular Fibrillation in J-Wave Syndrome.
    Shinohara T; Kondo H; Otsubo T; Fukui A; Yufu K; Nakagawa M; Takahashi N
    J Cardiovasc Electrophysiol; 2017 Mar; 28(3):321-326. PubMed ID: 27885745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Endocardial Ablation of Drug-Resistant Ventricular Fibrillation in Brugada Syndrome: Long-Term Outcome.
    Talib AK; Takagi M; Shimane A; Nakano M; Hayashi T; Okajima K; Kentaro M; Fukada K; Kowase S; Kurosaki K; Nitta J; Nishizaki M; Yui Y; Talib A; Sato N; Kawamura Y; Hasebe N; Aita S; Sai E; Komatsu Y; Kuroki K; Kaneshiro T; Dongzu X; Tajiri K; Igarashi M; Yamasaki H; Murakoshi N; Kumagai K; Sekiguchi Y; Nogami A; Aonuma K
    Circ Arrhythm Electrophysiol; 2018 Aug; 11(8):e005631. PubMed ID: 30354308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of non-type 1 anterior early repolarization in patients with inferolateral early repolarization syndrome.
    Kamakura T; Kawata H; Nakajima I; Yamada Y; Miyamoto K; Okamura H; Noda T; Satomi K; Aiba T; Takaki H; Aihara N; Kamakura S; Kimura T; Shimizu W
    J Am Coll Cardiol; 2013 Oct; 62(17):1610-8. PubMed ID: 23850930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Brugada Syndrome: Thirty-Three-Year Experience Using Electrophysiologically Guided Therapy With Class 1A Antiarrhythmic Drugs.
    Belhassen B; Rahkovich M; Michowitz Y; Glick A; Viskin S
    Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1393-402. PubMed ID: 26354972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ECG features and proarrhythmic potentials of therapeutic hypothermia.
    Lee WS; Nam GB; Kim SH; Choi JH; Jo U; Kim WY; Oh YS; Park KN; Seo GW; Kim KH; Jin ES; Rhee KS; Jung L; Hwang KW; Kim YR; Kwon CH; Kim J; Choi KJ; Kim YH
    Heart; 2016 Oct; 102(19):1558-65. PubMed ID: 27207979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk stratification in patients with Brugada syndrome without previous cardiac arrest – prognostic value of combined risk factors.
    Okamura H; Kamakura T; Morita H; Tokioka K; Nakajima I; Wada M; Ishibashi K; Miyamoto K; Noda T; Aiba T; Nishii N; Nagase S; Shimizu W; Yasuda S; Ogawa H; Kamakura S; Ito H; Ohe T; Kusano KF
    Circ J; 2015; 79(2):310-7. PubMed ID: 25428522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of T-wave alternans during night time as a predictor for ventricular fibrillation in patients with Brugada syndrome.
    Sakamoto S; Takagi M; Tatsumi H; Doi A; Sugioka K; Hanatani A; Yoshiyama M
    Heart Vessels; 2016 Jun; 31(6):947-56. PubMed ID: 25989739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term prognosis of patients withJ-wave syndrome.
    Kamakura T; Shinohara T; Yodogawa K; Murakoshi N; Morita H; Takahashi N; Inden Y; Shimizu W; Nogami A; Horie M; Aiba T; Kusano K
    Heart; 2020 Feb; 106(4):299-306. PubMed ID: 31391205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrical Substrate Elimination in 135 Consecutive Patients With Brugada Syndrome.
    Pappone C; Brugada J; Vicedomini G; Ciconte G; Manguso F; Saviano M; Vitale R; Cuko A; Giannelli L; Calovic Z; Conti M; Pozzi P; Natalizia A; Crisà S; Borrelli V; Brugada R; Sarquella-Brugada G; Guazzi M; Frigiola A; Menicanti L; Santinelli V
    Circ Arrhythm Electrophysiol; 2017 May; 10(5):e005053. PubMed ID: 28500178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk stratification of ventricular fibrillation in Brugada syndrome using noninvasive scoring methods.
    Kawazoe H; Nakano Y; Ochi H; Takagi M; Hayashi Y; Uchimura Y; Tokuyama T; Watanabe Y; Matsumura H; Tomomori S; Sairaku A; Suenari K; Awazu A; Miwa Y; Soejima K; Chayama K; Kihara Y
    Heart Rhythm; 2016 Oct; 13(10):1947-54. PubMed ID: 27424075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of asymptomatic Brugada patients with inducible ventricular fibrillation under hydroquinidine.
    Bouzeman A; Traulle S; Messali A; Extramiana F; Denjoy I; Narayanan K; Marijon E; Hermida JS; Leenhardt A
    Europace; 2014 Apr; 16(4):572-7. PubMed ID: 24068450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syncope in Brugada syndrome: prevalence, clinical significance, and clues from history taking to distinguish arrhythmic from nonarrhythmic causes.
    Olde Nordkamp LR; Vink AS; Wilde AA; de Lange FJ; de Jong JS; Wieling W; van Dijk N; Tan HL
    Heart Rhythm; 2015 Feb; 12(2):367-75. PubMed ID: 25311410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is this a philosophic issue? Do patients with drug-induced Brugada type ECG have poor prognosis? (Pro).
    Shimizu A
    Circ J; 2010 Nov; 74(11):2455-63. PubMed ID: 20962432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excellent long-term reproducibility of the electrophysiologic efficacy of quinidine in patients with idiopathic ventricular fibrillation and Brugada syndrome.
    Belhassen B; Glick A; Viskin S
    Pacing Clin Electrophysiol; 2009 Mar; 32(3):294-301. PubMed ID: 19272057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent ventricular fibrillation related to hypokalemia in early repolarization syndrome.
    Myojo T; Sato N; Nimura A; Matsuo A; Taniguchi O; Nakamura H; Karim Talib A; Sakamoto N; Takeuchi T; Kawamura Y; Hasebe N
    Pacing Clin Electrophysiol; 2012 Aug; 35(8):e234-8. PubMed ID: 22734973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.